文献速递肿瘤 PET/CT

局部晚期宫颈癌中早期与变化PET影像组学特征用于结局预测的探索性评估

An exploratory assessment of early and delta PET radiomic features for outcome prediction in locally advanced cervical cancer.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2025-06-18

该研究回顾性纳入95例接受新辅助放化疗后根治性手术的局部晚期宫颈癌患者,从基线及治疗开始两周后的[18F]FDG-PET图像提取影像组学特征并计算变化值。中位随访76.0个月,31.6%复发/进展,20.0%死于疾病;所有模型均无法预测无病生存(C指数≤0.72),总生存预测中早期特征影像组学与联合模型平均C指数均为0.75,变化特征模型分别为0.79和0.78,临床模型为0.76。

要点

  • 所有模型均不能预测局部晚期宫颈癌的无病生存,C指数≤0.72。
  • 基于早期特征的影像组学与联合模型预测总生存的平均C指数均为0.75。
  • 基于变化特征的影像组学与联合模型预测总生存的平均C指数分别为0.79和0.78,临床模型为0.76。

核心结论

  • 早期和变化[18F]FDG-PET影像组学特征不能预测接受新辅助放化疗后根治性手术的局部晚期宫颈癌患者的无病生存。
  • 影像组学和联合模型在总生存预测上较临床模型表现略有提高,但这些参数的附加价值及其纳入临床实践似乎有限。

研究设计与样本

  • 回顾性纳入2010年至2016年转诊至本机构的局部晚期宫颈癌患者。
  • 在新辅助放化疗前(基线)和治疗开始两周后(早期)行[18F]FDG-PET/CT,对原发肿瘤半自动勾画后提取影像组学特征,并计算基线与早期特征之间的相对差异作为变化影像组学。
  • 采用按复发和癌症特异性死亡分层的5折交叉验证,整合影像组学特征降维和折内重要性变量搜索,经监督特征选择后构建各时间点最佳特征影像组学模型、临床模型及联合模型,以C指数评估对无病生存和总生存的预测性能。

主要发现

  • 共纳入95例患者,中位随访76.0个月(95% CI:59.5-82.1),31.6%的患者出现复发/进展,20.0%死于疾病。
  • 无病生存预测:所有模型C指数≤0.72。
  • 总生存预测:基于早期特征的影像组学模型和联合模型平均C指数均为0.75;基于变化特征的影像组学模型和联合模型平均C指数分别为0.79和0.78;临床模型为0.76。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study investigated whether radiomic features extracted from [18F]FDG-PET scans acquired before and two weeks after neoadjuvant treatment, and their variation, provided prognostic parameters in locally advanced cervical cancer (LACC) patients treated with neoadjuvant chemo-radiotherapy (CRT) followed by radical surgery. METHODS: We retrospectively included LACC patients referred to our Institution from 2010 to 2016. [18F]FDG-PET/CT was performed before neoadjuvant CRT (baseline) and two weeks after the start of treatment (early). Radiomic features were extracted after semi-automatic delineation of the primary tumour, on baseline and early PET images. Delta radiomics were calculated as the relative differences between baseline and early features. We performed 5-fold cross-validation stratified for recurrence and cancer-specific death, integrating dimensionality reduction of the radiomic features and variable hunting with importance within the folds. After supervised feature selection, radiomic models with the best-performing features for each timepoint, as well as clinical models and combined clinico-radiomic models, were built. Model performances are presented as C-indices, for prediction of recurrence/progression (disease-free survival, DFS) and cancer-specific death (overall survival, OS). RESULTS: 95 patients were included. With a median follow-up of 76.0 months (95% CI: 59.5-82.1), 31.6% of patients had recurrence/progression and 20.0% died of disease. None of the models could predict DFS (C-indices ≤ 0.72). Model performances for OS yielded slightly better results, with mean C-indices of 0.75 for both the radiomic and combined model based on early features, 0.79 and 0.78 for the radiomic and combined model derived from delta features, and 0.76 for the clinical models. CONCLUSION: [18F]FDG-PET early and delta radiomic features could not predict DFS in patients with LACC treated with neoadjuvant CRT followed by radical surgery. Although slightly improved performances for the radiomic and combined models were observed in the prediction of OS compared to the clinical model, the added value of these parameters and their inclusion in the clinical practice seems to be limited.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Florit A, Noortman WA, Bizzarri N, et al. An exploratory assessment of early and delta PET radiomic features for outcome prediction in locally advanced cervical cancer. Eur J Nucl Med Mol Imaging. 2025. PMID: 40531232. doi:10.1007/s00259-025-07405-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。